ATE329006T1 - Teilchenverabreichung von therapeutischen mitteln im pulverisierten zustand - Google Patents

Teilchenverabreichung von therapeutischen mitteln im pulverisierten zustand

Info

Publication number
ATE329006T1
ATE329006T1 AT96109925T AT96109925T ATE329006T1 AT E329006 T1 ATE329006 T1 AT E329006T1 AT 96109925 T AT96109925 T AT 96109925T AT 96109925 T AT96109925 T AT 96109925T AT E329006 T1 ATE329006 T1 AT E329006T1
Authority
AT
Austria
Prior art keywords
therapeutic agents
powdered state
particle administration
particles
administration
Prior art date
Application number
AT96109925T
Other languages
English (en)
Inventor
Brian John Bellhouse
David Francis Sarphie
John Christopher Greenford
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939307459A external-priority patent/GB9307459D0/en
Priority claimed from GB939318407A external-priority patent/GB9318407D0/en
Priority claimed from GB939321356A external-priority patent/GB9321356D0/en
Priority claimed from GB939326069A external-priority patent/GB9326069D0/en
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Application granted granted Critical
Publication of ATE329006T1 publication Critical patent/ATE329006T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
    • A61M5/3015—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules for injecting a dose of particles in form of powdered drug, e.g. mounted on a rupturable membrane and accelerated by a gaseous shock wave or supersonic gas flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M35/00—Means for application of stress for stimulating the growth of microorganisms or the generation of fermentation or metabolic products; Means for electroporation or cell fusion
    • C12M35/04—Mechanical means, e.g. sonic waves, stretching forces, pressure or shear stimuli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/42—Reducing noise
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2053—Media being expelled from injector by pressurised fluid or vacuum

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicinal Preparation (AREA)
AT96109925T 1993-04-08 1994-04-08 Teilchenverabreichung von therapeutischen mitteln im pulverisierten zustand ATE329006T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB939307459A GB9307459D0 (en) 1993-04-08 1993-04-08 Particle delivery apparatus
GB939318407A GB9318407D0 (en) 1993-09-06 1993-09-06 Particle delivery apparatus
GB939321356A GB9321356D0 (en) 1993-10-15 1993-10-15 Particle delivery apparatus
GB939326069A GB9326069D0 (en) 1993-12-21 1993-12-21 Particle delivery apparatus

Publications (1)

Publication Number Publication Date
ATE329006T1 true ATE329006T1 (de) 2006-06-15

Family

ID=27451010

Family Applications (2)

Application Number Title Priority Date Filing Date
AT94912038T ATE148497T1 (de) 1993-04-08 1994-04-08 Nadellose spritze unter anwendung eines gasstroms mit überschallgeschwindigkeit zur verabreichung von partikeln
AT96109925T ATE329006T1 (de) 1993-04-08 1994-04-08 Teilchenverabreichung von therapeutischen mitteln im pulverisierten zustand

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT94912038T ATE148497T1 (de) 1993-04-08 1994-04-08 Nadellose spritze unter anwendung eines gasstroms mit überschallgeschwindigkeit zur verabreichung von partikeln

Country Status (32)

Country Link
US (5) US5630796A (de)
EP (4) EP1637173B1 (de)
JP (4) JP3260375B2 (de)
KR (1) KR100332147B1 (de)
CN (1) CN1109102C (de)
AT (2) ATE148497T1 (de)
AU (1) AU674742B2 (de)
BG (1) BG61993B1 (de)
BR (1) BR9406455A (de)
CA (1) CA2159452C (de)
CZ (1) CZ290476B6 (de)
DE (2) DE69434760T2 (de)
DK (2) DK0734737T3 (de)
ES (2) ES2098131T3 (de)
FI (1) FI120671B (de)
GR (1) GR3022939T3 (de)
HK (1) HK1000351A1 (de)
HU (2) HU216308B (de)
LV (1) LV11833B (de)
NO (1) NO314570B1 (de)
NZ (1) NZ263606A (de)
OA (1) OA10234A (de)
PL (1) PL174974B1 (de)
PT (1) PT734737E (de)
RO (1) RO118569B1 (de)
RU (1) RU2129021C1 (de)
SI (2) SI0693119T1 (de)
SK (1) SK283855B6 (de)
TJ (1) TJ248B (de)
TW (2) TW404844B (de)
UA (1) UA41360C2 (de)
WO (1) WO1994024263A1 (de)

Families Citing this family (337)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0679088T3 (da) 1992-09-29 2002-10-28 Inhale Therapeutic Syst Pulmonal levering af aktive fragmenter af parathyreoideaea hormon
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
WO1995019799A1 (en) * 1994-01-21 1995-07-27 Agracetus, Inc. Gas driven gene delivery instrument
DE69535897D1 (de) 1994-03-07 2009-01-22 Nektar Therapeutics Verfahren und Zusammensetzung für die pulmonale Darreichung von Insulin
US5899880A (en) * 1994-04-08 1999-05-04 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
ATE252373T1 (de) * 1994-08-04 2003-11-15 Elan Drug Delivery Ltd Feste verabreichungssysteme zur gesteuerten freisetzung von darin eingebauten molekülen sowie verfahren zu deren herstellung
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
GB9416663D0 (en) * 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
GB9426379D0 (en) * 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
GB9502879D0 (en) * 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
US5766901A (en) * 1995-05-04 1998-06-16 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for delivering a nucleotide into cell nuclei
US6474369B2 (en) 1995-05-26 2002-11-05 Penjet Corporation Apparatus and method for delivering a lyophilized active with a needle-less injector
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
GB9515846D0 (en) * 1995-08-02 1995-10-04 Boc Group Plc Gas capsule
EP0757202B1 (de) 1995-08-02 2003-05-14 The BOC Group plc Gaszuführvorrichtung
US6080130A (en) * 1998-11-14 2000-06-27 Castellano; Thomas P. Gas power source for a needle-less injector
US6013050A (en) * 1995-10-20 2000-01-11 Powderject Research Limited Particle delivery
GB9605690D0 (en) * 1996-03-19 1996-05-22 Oxford Biosciences Ltd Particle delivery
CA2257141C (en) * 1996-06-14 2006-11-28 Powderject Vaccines, Inc. Sample delivery module for particle acceleration apparatus
US6893664B1 (en) * 1996-06-17 2005-05-17 Powderject Research Limited Particle delivery techniques
EP0921827B1 (de) 1996-07-01 2003-10-22 Pharmacia Aktiebolag Abgabevorrichtung und deren bedienungsverfahren
CA2209406C (en) 1996-07-24 2007-05-15 David W. Birch Gas capsule and gas delivery system
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
DE19701494A1 (de) * 1997-01-17 1998-07-23 Boehringer Mannheim Gmbh Transdermales Injektionssystem
US5947928A (en) * 1997-06-19 1999-09-07 Mile Creek Capital, Llc Drug delivery system
EP0888791A1 (de) * 1997-07-04 1999-01-07 PowderJect Research Limited Spritze und dafür geeignete Medikamentenkapsel
EP0888790A1 (de) * 1997-07-04 1999-01-07 PowderJect Research Limited Vorrichtung zur Abgabe von Medikamententeilchen
US6074360A (en) 1997-07-21 2000-06-13 Boehringer Mannheim Gmbh Electromagnetic transdermal injection device and methods related thereto
US6171276B1 (en) 1997-08-06 2001-01-09 Pharmacia & Upjohn Ab Automated delivery device and method for its operation
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
DE19820172A1 (de) * 1997-09-30 2005-01-27 Wolfgang Wagner Einrichtung und einrichtungsbezogenes Verfahren zur Einbringung eines Diagnostikträgers oder einer Arznei unter die Haut eines Lebewesens
WO1999026662A1 (en) * 1997-11-20 1999-06-03 Aventis Pasteur A method for in vivo dna delivery using a needle free apparatus
CN1285753A (zh) * 1997-12-02 2001-02-28 鲍德杰克特疫苗公司 透皮给药微粒疫苗组合物
EP1038016A2 (de) * 1997-12-16 2000-09-27 Valentis Inc. Nadelloses injektion von formulierte nukleinsäure moleküle
GB9802506D0 (en) * 1998-02-05 1998-04-01 Boc Group Plc Needleless medical device
GB9802508D0 (en) * 1998-02-05 1998-04-01 Boc Group Plc Needleless medical device
AU5366099A (en) 1998-08-20 2000-03-14 Connaught Laboratories Limited Nucleic acid molecules encoding inclusion membrane protein of (chlamydia)
US6693087B1 (en) 1998-08-20 2004-02-17 Aventis Pasteur Limited Nucleic acid molecules encoding POMP91A protein of Chlamydia
US6686339B1 (en) 1998-08-20 2004-02-03 Aventis Pasteur Limited Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia
GB9818627D0 (en) * 1998-08-26 1998-10-21 Glaxo Group Ltd Improvements in dva vaccination
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
WO2000013573A1 (en) 1998-09-04 2000-03-16 Powderject Research Limited Monitoring methods using particle delivery methods
WO2000014547A1 (en) * 1998-09-04 2000-03-16 Powderject Research Limited Immunodiagnostics using particle delivery methods
US6602678B2 (en) 1998-09-04 2003-08-05 Powderject Research Limited Non- or minimally invasive monitoring methods
USD434848S (en) * 1998-09-08 2000-12-05 Powderject Research Limited Disposable injector
EP1117382B1 (de) * 1998-10-01 2005-05-11 PowderJect Research Limited Sprühbeschichtete mikropartikel für nadellose spritzen
JP2002527527A (ja) * 1998-10-19 2002-08-27 パウダージェクト ヴァクシンズ,インコーポレイテッド 最小プロモーターおよびその使用
FR2785293B1 (fr) 1998-10-30 2002-07-05 Pasteur Merieux Serums Vacc Acides nucleiques et polypeptides specifiques des souches pathogenes du genre neisseria
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
US6264629B1 (en) 1998-11-18 2001-07-24 Bioject, Inc. Single-use needle-less hypodermic jet injection apparatus and method
GB9825763D0 (en) * 1998-11-25 1999-01-20 Boc Group Plc Filling containers with gas
US20070196490A1 (en) * 1999-01-22 2007-08-23 Powderject Research Limited Method of enhancing needleless transdermal powered drug delivery
AU765429B2 (en) * 1999-01-22 2003-09-18 Powderject Research Limited Method of enhancing needleless transdermal powdered drug delivery
US6328714B1 (en) 1999-01-29 2001-12-11 Powderject Research Limited Particle delivery device
US6849060B1 (en) * 1999-01-29 2005-02-01 Powderject Research Limited Particle delivery device
AU780397B2 (en) 1999-02-03 2005-03-17 Powderject Research Limited Hydrogel particle formulations
US7022320B1 (en) 1999-02-09 2006-04-04 Powderject Vaccines, Inc. Mycobacterium tuberculosis immunization
US20050214227A1 (en) * 1999-03-08 2005-09-29 Powderject Research Limited Microparticle formulations for sustained-release of bioactive compounds
JP2002538195A (ja) * 1999-03-08 2002-11-12 パウダージェクト リサーチ リミテッド 生物活性化合物の持続放出用の無針注射器を使用する微粒子製剤の送達
GB9905933D0 (en) * 1999-03-15 1999-05-05 Powderject Res Ltd Neeedleless syringe
US7013617B2 (en) 1999-04-01 2006-03-21 The Boc Group, Plc Method of filling and sealing
US7060048B1 (en) * 1999-04-16 2006-06-13 Powerject Research Limited Needleless syringe
AU3957400A (en) 1999-04-16 2000-11-02 Novo Nordisk A/S Dry, mouldable drug formulation
MXPA01010470A (es) * 1999-04-16 2004-04-05 Powderject Res Ltd Jeringa sin agua.
WO2000067825A1 (en) 1999-05-07 2000-11-16 Microheart, Inc. Apparatus and method for delivering therapeutic and diagnostic agents
US7147633B2 (en) 1999-06-02 2006-12-12 Boston Scientific Scimed, Inc. Method and apparatus for treatment of atrial fibrillation
FR2796290B1 (fr) 1999-07-16 2001-09-14 Cross Site Technologies Seringue sans aiguille fonctionnant avec un generateur d'onde de choc a travers une paroi
FR2796288B1 (fr) * 1999-07-16 2001-08-10 Cross Site Technologies Seringue sans aiguille avec injecteur a elements emboites
GB9916800D0 (en) * 1999-07-16 1999-09-22 Powderject Res Ltd Needleless syringe
US20050027239A1 (en) * 1999-08-20 2005-02-03 Stout Richard R. Intradermal injection system for injecting DNA-based injectables into humans
US6319224B1 (en) * 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
US6811783B1 (en) 1999-09-07 2004-11-02 Aventis Pasteur Limited Immunogenic compositions for protection against chlamydial infection
DE19946059A1 (de) * 1999-09-25 2001-03-29 Roche Diagnostics Gmbh System zur transdermalen Gewinnung von Körperflüssigkeit
GB9923306D0 (en) 1999-10-01 1999-12-08 Isis Innovation Diagnostic and therapeutic epitope, and transgenic plant
EP1220697B1 (de) 1999-10-11 2004-12-29 Felton International, Inc. Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
CA2388301C (en) 1999-10-22 2011-01-04 Aventis Pasteur Limited Modified gp100 and uses thereof
AU778826B2 (en) * 1999-10-29 2004-12-23 Anges Mg, Inc. Gene therapy for diabetic ischemic disease
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US20040234539A1 (en) * 1999-11-03 2004-11-25 Powderject Research Limited Nucleic acid vaccine compositions having a mammalian cd80/cd86 gene promoter driving antigen expression
FR2800619B1 (fr) * 1999-11-05 2002-02-08 Cross Site Technologies Seringue sans aiguille avec un moyen de poussee temporairement retenu
US20040109874A1 (en) * 1999-11-10 2004-06-10 Powderject Vaccines, Inc. Induction of mucosal immunity by vaccination via the skin route
US6770054B1 (en) 1999-11-23 2004-08-03 Felton International, Inc. Injector assembly with driving means and locking means
US7029457B2 (en) 1999-11-23 2006-04-18 Felton International, Inc. Jet injector with hand piece
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
FR2802103B1 (fr) 1999-12-08 2003-10-03 Poudres & Explosifs Ste Nale Seringue sans aiguille fonctionnant avec entrainement du principe actif par effet tube a choc
FR2802102B1 (fr) * 1999-12-08 2002-07-12 Poudres & Explosifs Ste Nale Seringue sans aiguille munie d'un tube d'ejection a section constante
FR2802820B1 (fr) * 1999-12-27 2002-10-18 Poudres & Explosifs Ste Nale Seringue sans aiguille fonctionnant par effet tube a choc, avec maintien prealable du principe actif sur le cote
FR2804329B1 (fr) 2000-02-02 2002-12-13 Poudres & Explosifs Ste Nale Seringue sans aiguille munie d'un opercule contenant le principe actif
US6689092B2 (en) 2000-03-03 2004-02-10 Boehringer International Gmbh Needle-less injector of miniature type
GB0006263D0 (en) * 2000-03-15 2000-05-03 Powderject Res Ltd Apparatus and method for adjusting the characteristics of a needleless syringe
US6716190B1 (en) * 2000-04-19 2004-04-06 Scimed Life Systems, Inc. Device and methods for the delivery and injection of therapeutic and diagnostic agents to a target site within a body
EP1792995A3 (de) 2000-05-08 2007-06-13 Sanofi Pasteur Limited Chlamydia Antigene, entsprechende DNS Fragmente und ihre Verwendungen
US7851212B2 (en) 2000-05-10 2010-12-14 Sanofi Pasteur Limited Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001089633A2 (en) * 2000-05-26 2001-11-29 George Vizirgianakis Oxygen/air treatment and therapy apparatus
US20040213798A1 (en) * 2000-06-08 2004-10-28 Powderject Vaccines, Inc. Spray-dried alum compositions
US7597692B2 (en) * 2000-06-08 2009-10-06 Massachusetts Institute Of Technology Microscission processes and procedures
US6706032B2 (en) * 2000-06-08 2004-03-16 Massachusetts Institute Of Technology Localized molecular and ionic transport to and from tissues
CA2412197A1 (en) * 2000-06-08 2001-12-13 Powderject Vaccines, Inc. Powder compositions
US20020120228A1 (en) * 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
GB0018035D0 (en) 2000-07-21 2000-09-13 Powderject Res Ltd Needleless syringe
WO2002019989A2 (en) * 2000-09-08 2002-03-14 Powderject Research Limited Alginate particle formulation
US6824822B2 (en) * 2001-08-31 2004-11-30 Alkermes Controlled Therapeutics Inc. Ii Residual solvent extraction method and microparticles produced thereby
EP1322358A2 (de) * 2000-09-25 2003-07-02 Evit Laboratories, Inc. Vorrichtung und verfahren zur aerosolbildung mittels schockwellen
US6981660B2 (en) * 2000-09-25 2006-01-03 Evit Labs Shock wave aerosolization apparatus and method
GB0025147D0 (en) 2000-10-13 2000-11-29 Torsana Diabetes Diagnostics A Optical sensor for in situ measurement of analytes
ATE442858T1 (de) 2000-11-27 2009-10-15 Powderject Vaccines Inc Nukleinsäureadjuvantien
JP4434583B2 (ja) 2000-11-30 2010-03-17 バイオバルブ テクノロジーズ インコーポレイテッド 注射システム
GB0100756D0 (en) 2001-01-11 2001-02-21 Powderject Res Ltd Needleless syringe
US6644309B2 (en) * 2001-01-12 2003-11-11 Becton, Dickinson And Company Medicament respiratory delivery device and method
US6443152B1 (en) 2001-01-12 2002-09-03 Becton Dickinson And Company Medicament respiratory delivery device
US6722364B2 (en) * 2001-01-12 2004-04-20 Becton, Dickinson And Company Medicament inhalation delivery devices and methods for using the same
ES2191528B1 (es) * 2001-02-05 2004-06-16 Danone, S.A. Dispositivo para la dosificacion de substancias liquidas.
GB0103348D0 (en) * 2001-02-10 2001-03-28 Medical Res Council Delivery of biologically active agents
WO2002074406A1 (en) 2001-03-14 2002-09-26 Penjet Corporation System and method for removing dissolved gas from a solution
EP1377299A4 (de) 2001-03-19 2009-11-11 Intercell Usa Inc Transkutane immunstimulation
US6613010B2 (en) 2001-04-13 2003-09-02 Penjet Corporation Modular gas-pressured needle-less injector
US20050192530A1 (en) * 2001-04-13 2005-09-01 Penjet Corporation Method and apparatus for needle-less injection with a degassed fluid
EP1427463A2 (de) 2001-04-27 2004-06-16 PenJet Corporation Verfahren und vorrichtung zum befüllen und wiederbefüllen eines nadellosen injektors
DE10121255A1 (de) * 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
AU2002302814A1 (en) * 2001-06-08 2002-12-23 Powderject Vaccines, Inc. Spray freeze-dried compositions
US6648850B2 (en) * 2001-06-08 2003-11-18 Bioject, Inc. Durable needle-less jet injector apparatus and method
GB0118266D0 (en) * 2001-07-26 2001-09-19 Powderject Res Ltd Silencing device and method for needleless syringe
CA2454412C (en) * 2001-07-26 2010-03-30 Powderject Research Limited Particle cassette, method and kit therefor
US8061006B2 (en) * 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
US20030019558A1 (en) * 2001-07-26 2003-01-30 Smith Edward R. Particle cassette, method and kit therefor
DE10163327A1 (de) * 2001-07-30 2003-02-27 Disetronic Licensing Ag Reservoirmodul mit Kolbenstange
DE10163326A1 (de) * 2001-07-30 2003-02-27 Disetronic Licensing Ag Verabreichungsgerät mit Dosiervorrichtung
DE10163328B4 (de) * 2001-07-30 2005-08-11 Tecpharma Licensing Ag Verabreichungsgerät mit Verdrehsicherung
DE10163325B4 (de) * 2001-07-30 2005-07-28 Tecpharma Licensing Ag Verriegelungssperre für eine Verbindung von Gehäuseabschnitten eines Verabreichungsgeräts
DE20112501U1 (de) * 2001-07-30 2003-01-30 Disetronic Licensing Ag, Burgdorf Verriegelungssperre für eine Verbindung von Gehäuseteilen eines Injektions- oder Infusionsgeräts
US20050191361A1 (en) * 2001-08-03 2005-09-01 Powederject Research Ltd. Hydrogel particle formation
US6824526B2 (en) 2001-10-22 2004-11-30 Penjet Corporation Engine and diffuser for use with a needle-less injector
BR0214280A (pt) * 2001-11-19 2005-01-11 Becton Dickinson Co Composição farmacêuticas em forma particulada
EP1466007A1 (de) 2001-12-17 2004-10-13 Powderject Research Limited Nicht- oder minimal invasive überwachungsverfahren
US8454997B2 (en) 2001-12-18 2013-06-04 Novo Nordisk A/S Solid dose micro implant
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
DE20209051U1 (de) 2001-12-21 2003-05-28 Disetronic Licensing Ag, Burgdorf Injektionsgerät mit endpositionsblockiertem Dosiseinstellglied
US20030130614A1 (en) * 2002-01-09 2003-07-10 Johnson Lanny L. Device for delivering liquid medications or nutrients and gases to local tissue
JP4002892B2 (ja) * 2002-02-18 2007-11-07 ダンフォス アクチーセルスカブ 液体態様の薬物を投与するためのデバイス
US20030163111A1 (en) * 2002-02-26 2003-08-28 Daellenbach Keith K. End effector for needle-free injection system
CA2380671A1 (fr) * 2002-04-05 2003-10-05 Stephane Dufresne Seringue sans aiguille pour l'injection sous-cutanee de gouttelettes medicamenteuses
EP1356820A1 (de) 2002-04-26 2003-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) DNA-Impfstoff kombiniert mit einen Apoptoneauslöser von Tumorzellen
US7334580B2 (en) * 2002-05-07 2008-02-26 Smaldone Gerald C Methods, devices and formulations for targeted endobronchial therapy
US7607436B2 (en) * 2002-05-06 2009-10-27 The Research Foundation Of State University Of New York Methods, devices and formulations for targeted endobronchial therapy
US7156823B2 (en) * 2002-06-04 2007-01-02 Bioject Inc. High workload needle-free injection system
GB0212885D0 (en) 2002-06-05 2002-07-17 Isis Innovation Therapeutic epitopes and uses thereof
NZ539107A (en) 2002-09-27 2008-11-28 Powderject Res Ltd Nucleic acid coated particles
WO2004032963A2 (en) * 2002-10-04 2004-04-22 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
US7018356B2 (en) 2002-10-31 2006-03-28 Wise Roger R Method and apparatus for adjusting the contents of a needle-less injector
ATE474613T1 (de) * 2003-02-03 2010-08-15 Bioware Technology Co Ltd Genpistole mit niederdruckgasbeschleunigung
DE10306716A1 (de) * 2003-02-17 2004-09-02 Lell, Peter, Dr.-Ing. Vorrichtung zum Injizieren eines staub-oder pulverförmigen Stoffs in ein Gewebe eines Körpers
WO2004086938A2 (en) * 2003-03-25 2004-10-14 Herndon Terry O Drill device and method for forming microconduits
DE10316237A1 (de) * 2003-04-09 2004-11-04 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Kanüle und Verfahren zur Einführung einer Kanüle in biologisches Material
FR2853836B1 (fr) * 2003-04-16 2006-01-06 Crossject Seringue sans aiguille avec un injecteur-receptacle optimise
KR20060019518A (ko) * 2003-04-21 2006-03-03 스트라타젠트 라이프 사이언시즈 반복적 마이크로제트 약물 전달 장치 및 방법
US20060184101A1 (en) * 2003-04-21 2006-08-17 Ravi Srinivasan Microjet devices and methods for drug delivery
EP1647292A4 (de) * 2003-05-09 2011-02-23 Ryuichi Morishita Nadellose spritze mit darin aufgenommenem medizinischen mittel
US7589082B2 (en) 2003-06-13 2009-09-15 Skendi Finance Ltd Pharmaceutical formulation for contraception and hormone-replacement therapy
HU225252B1 (hu) * 2003-08-21 2006-08-28 S Istvan Lindmayer Tû nélküli injekciós berendezés
US7131961B2 (en) * 2003-10-01 2006-11-07 Bioject, Inc. Needle-free injection system
WO2005035771A2 (en) * 2003-10-10 2005-04-21 Powderject Vaccines, Inc. Nucleic acid constructs
US7442182B2 (en) * 2003-10-24 2008-10-28 Bioject, Inc. Spring powered needle-free injection system
US8147426B2 (en) * 2003-12-31 2012-04-03 Nipro Diagnostics, Inc. Integrated diagnostic test system
US20050209554A1 (en) * 2004-03-19 2005-09-22 Sergio Landau Needle-free single-use cartridge and injection system
US20050209553A1 (en) * 2004-03-19 2005-09-22 Sergio Landau Needle-free single-use cartridge and injection system
JP4210231B2 (ja) * 2004-03-25 2009-01-14 株式会社資生堂 皮膚のシワを改善する美容方法及びシワ改善具
CN1968700A (zh) * 2004-04-15 2007-05-23 阿尔克姆斯有限公司 聚合物基的持续释放装置
US20060110423A1 (en) * 2004-04-15 2006-05-25 Wright Steven G Polymer-based sustained release device
US7456254B2 (en) 2004-04-15 2008-11-25 Alkermes, Inc. Polymer-based sustained release device
WO2005105129A2 (en) 2004-04-28 2005-11-10 Btg International Limited Epitopes related to coeliac disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
EP1765294B1 (de) 2004-05-12 2008-09-24 Baxter International Inc. Nukleinsäure-mikrokügelchen, ihre herstellung und abgabe
US7884085B2 (en) 2004-05-12 2011-02-08 Baxter International Inc. Delivery of AS-oligonucleotide microspheres to induce dendritic cell tolerance for the treatment of autoimmune type 1 diabetes
US7717874B2 (en) * 2004-05-28 2010-05-18 Bioject, Inc. Needle-free injection system
US20060038044A1 (en) * 2004-08-23 2006-02-23 Van Steenkiste Thomas H Replaceable throat insert for a kinetic spray nozzle
US20060089593A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device for individual users
US20060089594A1 (en) * 2004-10-26 2006-04-27 Sergio Landau Needle-free injection device
BRPI0515759B8 (pt) 2004-12-01 2021-06-22 Acushot Inc dispositivo de injeção sem agulha e kit para utilização do mesmo
AU2006204120A1 (en) * 2005-01-06 2006-07-13 Benitec, Inc. RNAi agents for maintenance of stem cells
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006091459A2 (en) 2005-02-24 2006-08-31 Joslin Diabetes Center, Inc. Compositions and methods for treating vascular permeability
DE102005015801A1 (de) 2005-04-06 2006-10-19 Schreiner Group Gmbh & Co. Kg Folienbasierter Schutzmechanismus
US20070118093A1 (en) * 2005-06-20 2007-05-24 Von Muhlen Marcio G High-speed jet devices for drug delivery
US8591457B2 (en) * 2005-08-10 2013-11-26 Alza Corporation Method for making a needle-free jet injection drug delivery device
EP2258441A3 (de) 2005-09-02 2011-09-21 Intercell USA, Inc. Vorrichtungen für die transkutane Abgabe von Vakzinen und transdermale Abgabe von Arzneimitteln
WO2007073527A2 (en) * 2005-11-29 2007-06-28 Mitchell Stuart B Electrostatic transcutaneous hypodermic spray (electrostatic hypospray)
JP4402648B2 (ja) 2005-12-16 2010-01-20 オリンパス株式会社 被検体内導入装置
US20080161755A1 (en) * 2006-01-27 2008-07-03 Bioject Inc. Needle-free injection device and priming system
CA2640177A1 (en) 2006-01-31 2007-08-09 Novo Nordisk A/S Seal for a prefilled medical jet injection device
GB0611443D0 (en) 2006-06-09 2006-07-19 Powderject Res Ltd Improvements in, or relating to, particle cassettes
PL2359808T3 (pl) 2006-08-09 2013-10-31 Intarcia Therapeutics Inc Osmotyczne systemy dostawcze i zespoły tłokowe
CN100446823C (zh) * 2006-09-19 2008-12-31 宁波新芝生物科技股份有限公司 一种无创介入治疗系统
US7547293B2 (en) * 2006-10-06 2009-06-16 Bioject, Inc. Triggering mechanism for needle-free injector
CA2702340C (en) 2006-10-12 2014-12-16 The University Of Queensland Compositions and methods for modulating immune responses
FR2908753B1 (fr) * 2006-11-16 2011-11-11 Becton Dickinson France Dispositif pour delivrer automatiquement des doses successives de produit
DE102007004855B4 (de) 2007-01-31 2014-03-27 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Vorrichtung und Verfahren zur Deposition von biologischem Material in einem Zielsubstrat
JP2008199905A (ja) * 2007-02-16 2008-09-04 Snow Brand Milk Prod Co Ltd 乳酸菌生残性向上剤
WO2008103997A2 (en) * 2007-02-23 2008-08-28 Bioject Inc. Needle-free injection devices and drug delivery systems therefor
EP2157967B1 (de) 2007-04-23 2013-01-16 Intarcia Therapeutics, Inc Suspensionsformulierungen insulinotroper peptide und ihre verwendung
GB0708758D0 (en) 2007-05-04 2007-06-13 Powderject Res Ltd Particle cassettes and process thereof
CN104383556B (zh) 2007-05-16 2018-06-05 布里格姆妇女医院 突触核蛋白病的治疗
GB2479842B (en) 2007-05-18 2012-03-14 Malvern Instr Ltd Method and apparatus for dispersing a sample of particulate material
JP4780034B2 (ja) * 2007-05-18 2011-09-28 株式会社島津製作所 針無注射器
CA2703263C (en) 2007-11-01 2014-03-18 Perseid Therapeutics Llc Immunosuppressive polypeptides and nucleic acids
EP2240155B1 (de) 2008-02-13 2012-06-06 Intarcia Therapeutics, Inc Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
US20110117673A1 (en) * 2008-07-16 2011-05-19 Johnson Brandon T Methods and systems to collect and prepare samples, to implement, initiate and perform assays, and to control and manage fluid flow
US8021873B2 (en) 2008-07-16 2011-09-20 Boston Microfluidics Portable, point-of-care, user-initiated fluidic assay methods and systems
EP2353008A2 (de) 2008-09-22 2011-08-10 Oregon Health and Science University Verfahren zum nachweis einer infektion mit mycobacterium tuberculosis
DE102008048981A1 (de) * 2008-09-25 2010-04-15 Lts Lohmann Therapie-Systeme Ag Injektor und Zwei-Kammer-System mit sterilen Komponenten
US9207242B2 (en) 2008-10-09 2015-12-08 The University Of Hong Kong Cadherin-17 as diagnostic marker and therapeutic target for liver cancer
US8793075B2 (en) 2008-10-31 2014-07-29 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US9050070B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8731841B2 (en) * 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8762067B2 (en) * 2008-10-31 2014-06-24 The Invention Science Fund I, Llc Methods and systems for ablation or abrasion with frozen particles and comparing tissue surface ablation or abrasion data to clinical outcome data
US8409376B2 (en) 2008-10-31 2013-04-02 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8721583B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8551505B2 (en) * 2008-10-31 2013-10-08 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8788211B2 (en) * 2008-10-31 2014-07-22 The Invention Science Fund I, Llc Method and system for comparing tissue ablation or abrasion data to data related to administration of a frozen particle composition
US9072688B2 (en) * 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111857A1 (en) 2008-10-31 2010-05-06 Boyden Edward S Compositions and methods for surface abrasion with frozen particles
US9050317B2 (en) 2008-10-31 2015-06-09 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US20100111834A1 (en) * 2008-10-31 2010-05-06 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Compositions and methods for therapeutic delivery with frozen particles
US8731840B2 (en) 2008-10-31 2014-05-20 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8545855B2 (en) * 2008-10-31 2013-10-01 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9072799B2 (en) 2008-10-31 2015-07-07 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060934B2 (en) 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US8725420B2 (en) 2008-10-31 2014-05-13 The Invention Science Fund I, Llc Compositions and methods for surface abrasion with frozen particles
US9060926B2 (en) * 2008-10-31 2015-06-23 The Invention Science Fund I, Llc Compositions and methods for therapeutic delivery with frozen particles
US8232093B2 (en) 2009-02-05 2012-07-31 Indian Institute Of Science Apparatus and method for genetically transforming cells
JP2012519575A (ja) * 2009-03-09 2012-08-30 パーデュー・リサーチ・ファウンデーション 物質を迅速に混合し患者に送達するための小型装置
WO2010105096A2 (en) 2009-03-11 2010-09-16 University Of Massachusetts Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212)
EP2411519B1 (de) 2009-03-27 2015-07-22 Institut National de la Santé et de la Recherche Médicale Kanamycin-antisense-nucleinsäure zur behandlung von krebs
EP2756845B1 (de) 2009-04-03 2017-03-15 Dicerna Pharmaceuticals, Inc. Verfahren und Zusammensetzungen für spezifische KRAS-Hemmung mit asymmetrischer Doppelstrang-RNA
GB0906215D0 (en) 2009-04-09 2009-05-20 Lalvani Ajit Diagnostic test
TWI439302B (zh) 2009-07-14 2014-06-01 Chien Lung Chen 傳輸裝置
CN101987218B (zh) * 2009-07-30 2013-07-10 陈建龙 传输装置
EP3323423B1 (de) 2009-09-28 2020-06-17 Intarcia Therapeutics, Inc Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel
US20120208750A1 (en) 2009-09-29 2012-08-16 Joslin Diabetes Center, Inc. Use of protein kinase c delta (pkcd) inhibitors to treat diabetes, obesity, and hepatic steatosis
EP2501433A1 (de) * 2009-11-20 2012-09-26 Talima Therapeutics, Inc. Vorrichtung zur implantation von zusammensetzungen sowie verfahren und kits dafür
US8961989B2 (en) 2009-11-20 2015-02-24 Oregon Health & Science University Methods for producing an immune response to tuberculosis
CN201888971U (zh) * 2010-01-08 2011-07-06 江苏华兰米特医疗科技有限公司 无针注射器
US20130012916A1 (en) 2010-02-11 2013-01-10 Glide Pharmaceutical Technologies Limited Delivery of immunoglobulin variable domains and constructs thereof
CN101797411B (zh) * 2010-03-18 2011-12-07 傅雅芬 一种气压式无针注射器动力头
WO2011123762A1 (en) * 2010-04-01 2011-10-06 Glucago Llc Method and device for mixing substances
CA2798837A1 (en) 2010-06-07 2011-12-15 Pfizer Inc. Her-2 peptides and vaccines
CN103298507B (zh) * 2010-10-07 2015-08-26 麻省理工学院 采用线性洛仑兹力致动的无针射流注射系统递送固体和/或流体
US9211378B2 (en) 2010-10-22 2015-12-15 Cequr Sa Methods and systems for dosing a medicament
BR112013010926A2 (pt) 2010-11-01 2016-08-23 Univ Technology Sidney agentes imunomoduladores e seus usos
GB201021881D0 (en) * 2010-12-23 2011-02-02 Profibrix Bv Powder delivery device
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US8388569B2 (en) 2011-04-19 2013-03-05 Xerox Corporation Delivery devices and methods with collimated gas stream and particle source
US8430839B2 (en) 2011-04-19 2013-04-30 Palo Alto Research Center Incorporated Drug delivery devices and methods with collimated gas stream and drug reservoir
US8486002B2 (en) 2011-04-19 2013-07-16 Palo Alto Research Center Incorporated Drug delivery devices and methods with collimated gas stream and release-activatable tape
ES2490915B1 (es) 2011-09-12 2015-09-17 Laboratorios Del Dr. Esteve, S.A. Método para monitorizar las respuestas de linfocitos T citotóxicos (LTC) mediante una reacción de hipersensibilidad de tipo retardado usando epítopos de LTC definidos
EP2780456A1 (de) 2011-11-17 2014-09-24 The U.S.A. as represented by the Secretary, Department of Health and Human Services Therapeutische rna schalter-zusammensetzungen und anwendungsverfahren dafür
US20140058319A1 (en) * 2012-03-20 2014-02-27 Glucago Llc Compact Device For Rapidly Mixing and Delivering Substances To a Patient
US8992469B2 (en) 2012-06-26 2015-03-31 Glucago Llc Reconstitution device
USD728161S1 (en) 2012-08-08 2015-04-28 Young Nails Inc. Nail care device
US9125995B2 (en) 2012-12-05 2015-09-08 Glucago Llc Reconstitution devices
US9345487B2 (en) 2013-02-05 2016-05-24 Path Scientific, Llc Precision bone drill and method of use
WO2014128257A1 (en) 2013-02-22 2014-08-28 Sanofi Serpins: methods of therapeutic beta-cell regeneration and function
EP2851086A1 (de) 2013-09-20 2015-03-25 Sanofi Serpine: Verfahren zur therapeutischen ß-Zellen-Regeneration und Funktion
EP2769732A1 (de) 2013-02-22 2014-08-27 Sanofi Serpine: Verfahren zur therapeutischen Beta-Zellen-Regeneration und Funktion
CN105377355A (zh) 2013-03-14 2016-03-02 拇趾公司 治疗甲单元的感染、疾病或病症的方法
US9808579B2 (en) * 2013-05-08 2017-11-07 Elwha Llc Needleless injector systems, and related methods and components
WO2014183216A1 (en) * 2013-05-17 2014-11-20 Socpra Sciences Et Génie S.E.C. Needleless syringe and method for delivering therapeutic particles
CN106975128B (zh) * 2014-02-26 2021-02-26 普乐药业有限公司 用于递送颗粒的装置
WO2015171964A1 (en) * 2014-05-07 2015-11-12 Sri International Needle free injection device
US9737251B2 (en) 2014-05-28 2017-08-22 Verily Life Sciences Llc Needle-free blood draw
EP2959931A1 (de) * 2014-06-24 2015-12-30 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
EP3011988A1 (de) * 2014-10-22 2016-04-27 LTS LOHMANN Therapie-Systeme AG Nadellose Injektionsvorrichtung aufweisend ein Gel und eine Membran
WO2016077382A2 (en) 2014-11-11 2016-05-19 Massachusetts Eye & Ear Infirmary Conjunctivitis vaccines
EP3865576A1 (de) 2014-12-15 2021-08-18 Dicerna Pharmaceuticals, Inc. Ligandenmodifizierte doppelsträngige nukleinsäuren
US10078207B2 (en) 2015-03-18 2018-09-18 Endochoice, Inc. Systems and methods for image magnification using relative movement between an image sensor and a lens assembly
RS60762B1 (sr) 2015-04-03 2020-10-30 Univ Massachusetts Oligonukleotidna jedinjenja za ciljane irnk hantingtina
EP3929293A3 (de) 2015-04-03 2022-03-16 University Of Massachusetts Vollständig stabilisierte asymmetrische sirna
WO2016161378A1 (en) 2015-04-03 2016-10-06 University Of Massachusetts Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders
CA2985235A1 (en) 2015-05-07 2016-11-10 Shire Human Genetic Therapies, Inc. Glucocerebrosidase gene therapy for parkinson's disease
ES2968262T3 (es) 2015-06-03 2024-05-08 I2O Therapeutics Inc Sistemas de colocación de implantes
US20160361240A1 (en) * 2015-06-11 2016-12-15 The Procter & Gamble Company Apparatus and methods for modifying keratinous surfaces
US10842812B2 (en) 2015-08-12 2020-11-24 The General Hospital Corporation Compositions and methods that promote hypoxia or the hypoxia response for treatment and prevention of mitochondrial dysfunction and oxidative stress disorders
WO2017030973A1 (en) 2015-08-14 2017-02-23 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
AU2016332900C1 (en) 2015-09-29 2024-07-04 Amgen Inc. ASGR inhibitors
CA3005878A1 (en) 2015-11-19 2017-05-26 The Brigham And Women's Hospital, Inc. Lymphocyte antigen cd5-like (cd5l)-interleukin 12b (p40) heterodimers in immunity
US11027071B2 (en) * 2015-12-28 2021-06-08 Inovio Pharmaceuticals, Inc. Intradermal jet injection electroporation device
WO2017132669A1 (en) 2016-01-31 2017-08-03 University Of Massachusetts Branched oligonucleotides
KR20240037175A (ko) 2016-05-16 2024-03-21 인타르시아 세라퓨틱스 인코포레이티드 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
WO2018031933A2 (en) 2016-08-12 2018-02-15 University Of Massachusetts Conjugated oligonucleotides
US10443055B2 (en) 2016-12-22 2019-10-15 Beth Israel Deaconess Medical Center Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
AU2018206539A1 (en) 2017-01-03 2019-07-18 Intarcia Therapeutics, Inc. Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
WO2018237245A1 (en) 2017-06-23 2018-12-27 University Of Massachusetts TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS
WO2019033114A1 (en) 2017-08-11 2019-02-14 Dana-Farber Cancer Institute, Inc. USE OF BOTULINUM TOXIN AGENT FOR THE TREATMENT OF PLASMOCYTE DISORDERS
WO2019036375A1 (en) 2017-08-14 2019-02-21 Sanford Burnham Prebys Medical Discovery Institute CARDIOGENIC MESODERMA TRAINING REGULATORS
WO2019089216A1 (en) 2017-11-01 2019-05-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancers
CN108553748A (zh) * 2018-05-11 2018-09-21 江秀秀 B超监视下体内多种细胞植入仪
AU2019266550A1 (en) 2018-05-11 2020-11-26 Alpha Anomeric Sas Oligonucleotides conjugates comprising 7'-5'-alpha-anomeric-bicyclic sugar nucleosides
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
BR112021002440A2 (pt) 2018-08-10 2021-05-04 University Of Massachusetts oligonucleotídeos modificados visando snps
WO2020041769A1 (en) 2018-08-23 2020-02-27 University Of Massachusetts O-methyl rich fully stabilized oligonucleotides
CA3110661A1 (en) 2018-08-29 2020-03-05 University Of Massachusetts Inhibition of protein kinases to treat friedreich ataxia
KR102199724B1 (ko) * 2018-10-05 2021-01-07 주식회사 피테크 무바늘 무통 주사 장치
KR20250116790A (ko) 2018-12-12 2025-08-01 카이트 파마 인코포레이티드 키메라 항원 수용체 및 car-t 세포 및 사용 방법
WO2020146758A1 (en) 2019-01-10 2020-07-16 The General Hospital Corporation Methods to treat mitochondrial-associated dysfunctions or diseases
CN113614232A (zh) 2019-01-18 2021-11-05 马萨诸塞大学 动态药代动力学修饰锚
US12377046B1 (en) 2019-04-24 2025-08-05 Wellomics LLC Delivery system matrices
EP3966328A4 (de) 2019-05-06 2023-10-18 University Of Massachusetts Anti-c9orf72-oligonukleotide und zugehörige verfahren
IT201900007060A1 (it) 2019-05-21 2020-11-21 St Superiore Di Sanita Cellule tumorali ingegnerizzate e loro usi
CN110038212A (zh) * 2019-05-29 2019-07-23 徐小棠 一种呼吸内科护理给药多用装置
ES3041245T3 (en) 2019-05-30 2025-11-11 Viti Inc Methods for detecting a mycobacterium tuberculosis infection
CN110180051B (zh) * 2019-07-13 2021-04-02 河南省中医院(河南中医药大学第二附属医院) 产科护理用清洗装置
IT201900012540A1 (it) 2019-07-22 2021-01-22 Humanitas Mirasole Spa Inibitori di CHI3L1 e loro usi
KR20220047989A (ko) 2019-08-09 2022-04-19 유니버시티 오브 매사추세츠 Snp를 표적화하는 화학적으로 변형된 올리고뉴클레오타이드
US12365894B2 (en) 2019-09-16 2025-07-22 University Of Massachusetts Branched lipid conjugates of siRNA for specific tissue delivery
US12037585B2 (en) 2019-12-23 2024-07-16 University Of Massachusetts Oligonucleotides for tissue specific gene expression modulation
EP4103715A4 (de) 2020-02-14 2024-03-06 University Of Massachusetts Gegen frataxin gerichtete oligonukleotide und zugehörige verfahren
EP4110913A4 (de) 2020-02-28 2024-07-24 University of Massachusetts Oligonukleotide zur prnp-modulation
US20230220085A1 (en) 2020-02-28 2023-07-13 The Brigham And Women’S Hospital, Inc. Selective modulation of transforming growth factor beta superfamily signaling via multi-specific antibodies
AU2021244600A1 (en) 2020-03-26 2022-11-03 University Of Massachusetts Synthesis of modified oligonucleotides with increased stability
US12344839B2 (en) 2020-03-27 2025-07-01 University Of Massachusetts Dual-acting siRNA based modulation of C9orf72
WO2021216378A1 (en) 2020-04-23 2021-10-28 The Schepens Eye Research Institute, Inc. Methods and materials for treatment of fibrosis
CN111569194A (zh) * 2020-05-06 2020-08-25 许昌学院 一种糖尿病用胰岛素注射器
CA3174079A1 (en) 2020-05-26 2021-12-02 Anastasia Khvorova Synthetic oligonucleotides having regions of block and cluster modifications
GB202105455D0 (en) 2021-04-16 2021-06-02 Ucl Business Ltd Composition
IL309334A (en) 2021-06-23 2024-02-01 Univ Massachusetts Anti-FLT1 optimized oligonucleotide compounds for the treatment of preeclampsia and other angiogenic disorders
CN118139663A (zh) * 2021-06-24 2024-06-04 阿维塔斯有限公司 喷雾喷嘴
GB202112471D0 (en) 2021-09-01 2021-10-13 King S College London Microna systems
US20240075265A1 (en) * 2022-09-07 2024-03-07 Particle Vaccine Canada Ltd. Method and apparatus for epidermal delivery of powdered medicaments
WO2024200831A1 (en) 2023-03-30 2024-10-03 Vivadju Pvax14 nucleic acid in combination with all-trans retinoic acid (atra) and a checkpoint inhibitor for the treatment of cancer
WO2026117631A2 (en) 2024-11-26 2026-06-04 City Therapeutics, Inc. Factor xi rnai agent compositions and methods of use thereof

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE170094C (de)
US1300654A (en) 1919-01-30 1919-04-15 William H Rose Dry-spraying machine.
US2151418A (en) 1937-05-12 1939-03-21 Scott & Bowne Powder applicator
US2147158A (en) 1937-09-28 1939-02-14 Goldenthal Philip Powder insufflator
US2307986A (en) 1940-02-15 1943-01-12 Bolte Insufflator
US2605763A (en) * 1948-01-31 1952-08-05 Becton Dickinson Co Injection device
GB677523A (en) * 1948-04-13 1952-08-20 Becton Dickinson Co Discharge structure for hypodermic injection device
US2478715A (en) 1948-07-14 1949-08-09 Vilbiss Co Powder blower
US2594093A (en) 1949-02-05 1952-04-22 Armour & Co Powder container
US2470298A (en) 1949-02-07 1949-05-17 Abbott Lab Powdered medicine dispenser
DE1047385B (de) * 1952-03-08 1958-12-24 Armour & Co Puderzerstaeuber mit einem auswechselbaren Puderbehaelter
US3216562A (en) 1963-06-13 1965-11-09 Driaire Inc Easy-open capsule
IL28680A (en) 1966-12-16 1971-12-29 American Home Prod Stabilized aqueous suspensions of benzathine penicillin
US3674028A (en) * 1969-06-04 1972-07-04 Ims Ltd Multi-mix
US3736933A (en) * 1970-12-02 1973-06-05 B Szabo Burstable seamed hypodermic applicators
US3788315A (en) * 1971-04-20 1974-01-29 S Laurens Disposable cutaneous transjector
US3914573A (en) * 1971-05-17 1975-10-21 Geotel Inc Coating heat softened particles by projection in a plasma stream of Mach 1 to Mach 3 velocity
US3853125A (en) * 1971-10-05 1974-12-10 W Clark Disposable needleless injector
US3782380A (en) * 1973-01-04 1974-01-01 Gaast H V D Medicament injecting device
US4069819A (en) * 1973-04-13 1978-01-24 Societa Farmaceutici S.P.A. Inhalation device
US3946732A (en) * 1973-08-08 1976-03-30 Ampoules, Inc. Two-chamber mixing syringe
US3967761A (en) 1974-04-08 1976-07-06 Southwest Research Institute System for injecting particulate material into the combustion chamber of a repetitive combustion coating apparatus
US3952741A (en) * 1975-01-09 1976-04-27 Bend Research Inc. Controlled release delivery system by an osmotic bursting mechanism
US3982605A (en) * 1975-05-05 1976-09-28 The Carborundum Company Nozzle noise silencer
FR2360031A1 (fr) * 1976-07-27 1978-02-24 Klein Max Dispositif distributeur silencieux d'un jet de gaz et application au diagnostic medical
JPS602489B2 (ja) * 1977-05-02 1985-01-22 株式会社豊田中央研究所 低騒音用圧力流体放出装置
EP0006724B1 (de) * 1978-06-16 1982-12-01 Phares Pharmaceutical Research N.V. Harnstoff enthaltende pharmazeutische Zusammensetzungen
US4226236A (en) * 1979-05-07 1980-10-07 Abbott Laboratories Prefilled, vented two-compartment syringe
US4778054A (en) 1982-10-08 1988-10-18 Glaxo Group Limited Pack for administering medicaments to patients
DK172541B1 (da) 1982-10-08 1998-12-07 Glaxo Group Ltd Apparat til administrering af medikamenter til patienter og en medikamentpakning til brug i apparatet
US4515586A (en) 1982-11-30 1985-05-07 Abbott Laboratories Powder syringe mixing system
US4652261A (en) * 1984-06-22 1987-03-24 Regents Of The University Of Minnesota Drug-injection animal capture collar
US5036006A (en) * 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4945050A (en) * 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) * 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US4596556A (en) * 1985-03-25 1986-06-24 Bioject, Inc. Hypodermic injection apparatus
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
DK179286D0 (da) 1986-04-18 1986-04-18 Nordisk Gentofte Insulinpraeparat
USRE33801E (en) 1986-05-09 1992-01-21 Dentsply Research & Development Corp. Mixing and discharge capsule
US5120657A (en) 1986-12-05 1992-06-09 Agracetus, Inc. Apparatus for genetic transformation
IN170021B (de) * 1987-05-26 1992-01-25 Deita Freyberg Gmbh
GB2206794A (en) * 1987-07-14 1989-01-18 Richard Kiteley Power Syringe
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5179022A (en) * 1988-02-29 1993-01-12 E. I. Du Pont De Nemours & Co. Biolistic apparatus for delivering substances into cells and tissues in a non-lethal manner
BR8801952A (pt) * 1988-04-22 1989-11-14 Sergio Landau Capsula descartavel,nao re-utilizavel,contendo dose individual de vacina a ser injetada hipodermicamente,sem agulha,com aparelho injetor a pressao
FR2638359A1 (fr) * 1988-11-03 1990-05-04 Tino Dalto Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau
FI914898A0 (fi) * 1989-04-20 1991-10-17 Sinai School Medicine Leverspecifika insulinanaloger.
US5239991A (en) 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
HU200699B (en) * 1989-07-05 1990-08-28 Gyula Erdelyi Neddleless hypodermic syringe particularly for blinds and poor-sighted persons
GB8918879D0 (en) * 1989-08-18 1989-09-27 Danbiosyst Uk Pharmaceutical compositions
US5064413A (en) * 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
AU7558991A (en) * 1990-03-15 1991-10-10 United States Of America, As Represented By The Secretary Of The Army, The Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
US5062830A (en) * 1990-04-04 1991-11-05 Derata Corporation Dry disposable nozzle assembly for medical jet injector
GB9011588D0 (en) * 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US5204253A (en) * 1990-05-29 1993-04-20 E. I. Du Pont De Nemours And Company Method and apparatus for introducing biological substances into living cells
US5149655A (en) * 1990-06-21 1992-09-22 Agracetus, Inc. Apparatus for genetic transformation
IT1243344B (it) 1990-07-16 1994-06-10 Promo Pack Sa Inalatore plurimonodose per medicamenti in polvere
GB9016789D0 (en) * 1990-07-31 1990-09-12 Lilly Industries Ltd Medicament administering devices
WO1992004439A1 (en) * 1990-08-30 1992-03-19 Brian John Bellhouse Ballistic apparatus
US5042472A (en) 1990-10-15 1991-08-27 Merck & Co., Inc. Powder inhaler device
US5188615A (en) 1990-11-19 1993-02-23 Habley Medical Technology Corp. Mixing vial
US5046618A (en) 1990-11-19 1991-09-10 R. P. Scherer Corporation Child-resistant blister pack
DK288590D0 (da) * 1990-12-04 1990-12-04 Michael Morris Blandings/oploesnings-sproejte til cytostatika for medicinsk behandling af cancer patienter
GB9027422D0 (en) * 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5360410A (en) 1991-01-16 1994-11-01 Senetek Plc Safety syringe for mixing two-component medicaments
GB9100950D0 (en) * 1991-01-16 1991-02-27 Dunne Miller Weston Ltd Metered dose atomising and delivery device
US5492112A (en) 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5102388A (en) 1991-07-15 1992-04-07 Richmond John E Sequential delivery syringe
GB9118204D0 (en) * 1991-08-23 1991-10-09 Weston Terence E Needle-less injector
EP0558879B1 (de) 1992-03-04 1997-05-14 Astra Aktiebolag Wegwerfinhalator
DK0659150T3 (da) 1992-09-09 1997-09-29 Fisons Plc Farmaceutisk emballage.
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
US5349947A (en) * 1993-07-15 1994-09-27 Newhouse Michael T Dry powder inhaler and process that explosively discharges a dose of powder and gas from a soft plastic pillow
US5415162A (en) 1994-01-18 1995-05-16 Glaxo Inc. Multi-dose dry powder inhalation device
WO1995019799A1 (en) 1994-01-21 1995-07-27 Agracetus, Inc. Gas driven gene delivery instrument
US5483954A (en) 1994-06-10 1996-01-16 Mecikalski; Mark B. Inhaler and medicated package
JP3320261B2 (ja) * 1995-06-01 2002-09-03 株式会社ユニシアジェックス 吸入式投薬器

Also Published As

Publication number Publication date
SK124895A3 (en) 1997-01-08
LV11833B (en) 1997-12-20
DK0693119T3 (da) 1997-07-28
DK0734737T3 (da) 2006-10-09
DE69434760T2 (de) 2007-05-16
JPH08509604A (ja) 1996-10-15
US20070299390A1 (en) 2007-12-27
US6168587B1 (en) 2001-01-02
DE69434760D1 (de) 2006-07-20
NZ263606A (en) 1997-08-22
PL311005A1 (en) 1996-01-22
US5630796A (en) 1997-05-20
EP0734737B1 (de) 2006-06-07
UA41360C2 (uk) 2001-09-17
JP2007051160A (ja) 2007-03-01
BG61993B1 (bg) 1998-12-30
GR3022939T3 (en) 1997-06-30
EP0951917A2 (de) 1999-10-27
EP1637173A3 (de) 2007-09-05
US6881200B2 (en) 2005-04-19
CN1109102C (zh) 2003-05-21
ATE148497T1 (de) 1997-02-15
FI120671B (fi) 2010-01-29
ES2267106T3 (es) 2007-03-01
DE69401651T2 (de) 1997-05-15
EP0951917A3 (de) 2000-01-05
TW360548B (en) 1999-06-11
EP0693119A1 (de) 1996-01-24
US20050165348A1 (en) 2005-07-28
US7618394B2 (en) 2009-11-17
CZ260895A3 (en) 1996-05-15
TW404844B (en) 2000-09-11
KR100332147B1 (ko) 2002-08-14
US7942846B2 (en) 2011-05-17
SK283855B6 (sk) 2004-03-02
FI954788L (fi) 1995-10-06
JP3260375B2 (ja) 2002-02-25
SI0734737T1 (sl) 2006-10-31
HU9802714D0 (en) 1999-01-28
HU9502911D0 (en) 1995-12-28
EP0693119B1 (de) 1997-01-29
ES2098131T3 (es) 1997-04-16
HU228144B1 (en) 2012-12-28
JP2002179557A (ja) 2002-06-26
US20020188248A1 (en) 2002-12-12
EP1637173A2 (de) 2006-03-22
OA10234A (en) 1997-10-07
PT734737E (pt) 2006-09-29
PL174974B1 (pl) 1998-10-30
EP0734737A3 (de) 1997-03-12
RO118569B1 (ro) 2003-07-30
BG100047A (bg) 1996-04-30
HK1000351A1 (en) 1998-03-06
LV11833A (lv) 1997-08-20
NO314570B1 (no) 2003-04-14
TJ248B (en) 1999-12-23
NO953994L (no) 1995-10-06
EP0734737A2 (de) 1996-10-02
CZ290476B6 (cs) 2002-07-17
RU2129021C1 (ru) 1999-04-20
CA2159452A1 (en) 1994-10-27
EP1637173B1 (de) 2014-05-21
CN1120852A (zh) 1996-04-17
WO1994024263A1 (en) 1994-10-27
AU674742B2 (en) 1997-01-09
HUT73516A (en) 1996-08-28
JP2006320737A (ja) 2006-11-30
FI954788A0 (fi) 1995-10-06
BR9406455A (pt) 1996-01-02
CA2159452C (en) 2000-11-21
HU216308B (hu) 1999-06-28
DE69401651D1 (de) 1997-03-13
SI0693119T1 (en) 1997-10-31
JP4430636B2 (ja) 2010-03-10
NO953994D0 (no) 1995-10-06
AU6435194A (en) 1994-11-08

Similar Documents

Publication Publication Date Title
DE69434760D1 (de) Teilchenverabreichung von therapeutischen Mitteln im pulverisierten Zustand
UA32541C2 (uk) Пристрій інжектора рідини, спосіб введення рідкого лікарського засобу
ATE189403T1 (de) Vorrichtung zum verabreichen von pharmazeutischen substanzen
MY109074A (en) Method of terminal steam sterilization
EP0850648A3 (de) Zusammensetzungen aus einer thrombolytisch wirkende Substanz und Antikoagulantien, und ihre Verwendungen
ATE236585T1 (de) Vorgefüllte fluidspritze
ES2012256A6 (es) Un conector y para usarse en un procedimiento de angioplastia.
WO2001003757A3 (en) Medical fluid delivery system
ATE435294T1 (de) Verabreichung von biologisch aktiven polypeptiden
ATE195916T1 (de) Verfahren zum füllen einer medizinkapsel und dabei erzeugter gegenstand
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
DK1196210T3 (da) Injektionsspröjte uden nål
JPS52130922A (en) Remedy for cerebral blood flow disorders containing coenzyme-q as main ingredient
AU1193588A (en) Vented spike connection component
Savvaitova et al. Clinical course of pneumoconiosis after exposure to dust evaluated by the results of ambulatory follow-up
BG48390A1 (en) Composition for medical rubber items

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0734737

Country of ref document: EP